Rivus Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Rivus Pharmaceuticals?

Rivus Pharmaceuticals has 6 investors including RxCapital And BB Biotech Ventures.

Q: How much funding has Rivus Pharmaceuticals raised to date?

Rivus Pharmaceuticals has raised obfuscated.

Overview

Rivus Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Rivus Pharmaceuticals

CB Rank

18539

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

Founded

obfuscation

Private

Venture - Series Unknown

Charlottesville, Virginia, United States

11-50

www.rivuspharma.com

Biotechnology

Health Care

Medical

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Jayson Dallas: Executive Chairman
Allen Cunningham: Chief Executive Officer

Details

Legal Name

Rivus Pharmaceuticals, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Allen Cunningham

About the Company

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.

Contact Email

info@rivuspharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Rivus Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

HU6

An oral small molecule controlled metabolic accelerator designed to reduce excess fat and treat cardiometabolic diseases by activating mitochondrial uncoupling.

RV-200

An investigational controlled metabolic accelerator targeting obesity and cardiovascular disease by activating mitochondrial uncoupling.

Research & Development

Rivus Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Rivus Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
RxCapital	—	Series B - Rivus Pharmaceuticals	—
RxCapital	—	Series B - Rivus Pharmaceuticals	—
RxCapital	—	Series B - Rivus Pharmaceuticals	—
RxCapital	—	Series B - Rivus Pharmaceuticals	—
RxCapital	—	Series B - Rivus Pharmaceuticals	—